Integer (NYSE:ITGR) Stock Rating Lowered by Truist Financial

Integer (NYSE:ITGR) was downgraded by Truist Financial from a “strong-buy” rating to a “hold” rating in a research note issued on Monday,Zacks.com reports.

Several other research analysts have also recently issued reports on the stock. HC Wainwright reissued a “buy” rating on shares of Integer in a report on Friday, July 24th. Freedom Capital raised Integer to a “strong-buy” rating in a report on Wednesday, July 22nd. Oppenheimer cut Integer from an “outperform” rating to a “market perform” rating in a research report on Monday. Zacks Research raised Integer from a “strong sell” rating to a “hold” rating in a research note on Monday, July 20th. Finally, Piper Sandler cut Integer from an “overweight” rating to a “neutral” rating and set a $127.00 price target for the company. in a report on Monday. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and twelve have assigned a Hold rating to the company. According to data from MarketBeat, Integer presently has a consensus rating of “Hold” and a consensus price target of $103.71.

Integer Stock Performance

Shares of ITGR opened at $124.44 on Monday. The stock has a market capitalization of $4.23 billion, a P/E ratio of 31.03, a P/E/G ratio of 2.89 and a beta of 0.61. The company has a debt-to-equity ratio of 0.77, a quick ratio of 2.38 and a current ratio of 3.75. Integer has a 1 year low of $62.00 and a 1 year high of $125.54. The company’s fifty day moving average is $94.58 and its two-hundred day moving average is $89.28.

Integer (NYSE:ITGR) last released its earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 EPS for the quarter, topping the consensus estimate of $1.38 by $0.22. The company had revenue of $464.11 million during the quarter, compared to analysts’ expectations of $450.67 million. Integer had a net margin of 7.64% and a return on equity of 12.83%. The business’s revenue was down 2.6% on a year-over-year basis. During the same quarter last year, the business earned $1.55 EPS. On average, sell-side analysts predict that Integer will post 6.04 earnings per share for the current year.

Hedge Funds Weigh In On Integer

A number of large investors have recently made changes to their positions in ITGR. EverSource Wealth Advisors LLC increased its holdings in Integer by 48.1% in the first quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider’s stock valued at $32,000 after buying an additional 117 shares in the last quarter. Salomon & Ludwin LLC lifted its position in shares of Integer by 46.8% during the 4th quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 118 shares during the period. Kestra Advisory Services LLC lifted its position in shares of Integer by 0.6% during the 4th quarter. Kestra Advisory Services LLC now owns 21,424 shares of the medical equipment provider’s stock valued at $1,680,000 after acquiring an additional 136 shares during the period. Orion Porfolio Solutions LLC boosted its stake in shares of Integer by 1.4% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 9,755 shares of the medical equipment provider’s stock worth $1,200,000 after acquiring an additional 138 shares in the last quarter. Finally, Lido Advisors LLC boosted its stake in shares of Integer by 5.5% during the 4th quarter. Lido Advisors LLC now owns 2,887 shares of the medical equipment provider’s stock worth $226,000 after acquiring an additional 151 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Key Integer News

Here are the key news stories impacting Integer this week:

• Positive Sentiment: KKR will pay Integer shareholders $127 per share, representing premiums of approximately 51.8% to the April 29 closing price and 28.8% to the 30-day volume-weighted average price. The cash offer provides investors with a defined exit value and is the primary reason for the stock’s rise. Integer to Be Acquired by KKR
• Positive Sentiment: Second-quarter results also exceeded expectations: adjusted earnings were $1.60 per share versus the $1.38 consensus estimate, while revenue of $464.1 million topped the $450.7 million forecast. Earnings rose from $1.55 per share a year earlier. Integer Q2 Earnings and Revenues Top Estimates
• Neutral Sentiment: The transaction is expected to close by year-end 2026, subject to shareholder and regulatory approvals. Integer’s board unanimously approved the deal, and there is no financing contingency. If completed, Integer will become private and its shares will no longer trade on the NYSE. KKR said it intends to invest in capacity, technology, innovation and employee ownership.
• Negative Sentiment: Integer withdrew its previously issued financial outlook and canceled its scheduled earnings call because of the pending acquisition. Revenue nevertheless declined 2.6% year over year, highlighting softer underlying growth despite the earnings beat. Integer Reports Second Quarter 2026 Results
• Negative Sentiment: Several law firms announced investigations into whether Integer’s directors obtained a fair price and complied with fiduciary duties in the KKR transaction. These announcements are common in takeovers but could create litigation, delay or deal-completion risks. Ademi Integer Shareholder Alert

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.